Erythrodysesthesia: An Unusual Complication With Trastuzumab Monotherapy.
| Autor: | Fontenot AL; Medicine, Louisiana State University Health Shreveport, Shreveport, USA., Furr WJ; Medicine, Louisiana State University Health Shreveport, Shreveport, USA., Husan A; Medicine, Louisiana State University Health Shreveport, Shreveport, USA., Khan MW; Medicine, Louisiana State University Health Shreveport, Shreveport, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2021 Nov 30; Vol. 13 (11), pp. e20060. Date of Electronic Publication: 2021 Nov 30 (Print Publication: 2021). |
| DOI: | 10.7759/cureus.20060 |
| Abstrakt: | Palmar-plantar erythrodysesthesia (PPE), more commonly known as hand-foot syndrome, is a dermatologic complication following chemotherapy with selective agents. In this article, we present the case of a young lady with stage III breast cancer who developed palmar-plantar erythrodysesthesia following treatment with Herceptin (trastuzumab), an unusual complication of this particular drug. From our review of literature, this is the second known occurrence of PPE secondary to trastuzumab monotherapy. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2021, Fontenot et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|